Nutrien is no longer asking the market to pay a peak-cycle fertilizer multiple for a sprawling four-nutrient conglomerate. The first half of the year showed the company running potash at record throughput while recycling roughly a billion of non-core proceeds into a faster share repurchase program and a lower capital-spend plan. Second-quarter adjusted earnings before interest, tax, depreciation and amortization slipped a couple of points as nitrogen tonnes and sulfur costs offset better realized prices. That print is the reason the equity still sits well below the fifty-two-week high even as first-half cash from operations rose. The investment debate is whether that softness is the start of a mean-reversion or the cost of a cleaner, more cash-generative platform.
The operating split underneath the headline is the real story. Potash first-half adjusted earnings rose to about $1.24 billion on higher global benchmarks and record sales tonnes, with controllable cash cost of product manufactured held below sixty per tonne. Retail first-half adjusted earnings also reached about $1.24 billion, but the second quarter itself slipped because crop-nutrient volumes and fuel costs outweighed a jump in proprietary-product gross margin. Nitrogen first-half earnings improved on cheaper North American gas and stronger benchmarks, yet second-quarter tonnes fell after the Trinidad controlled shutdown and the New Madrid closure. Phosphate is the open wound. Selling prices rose and volumes rose, and the segment still posted a negative gross margin because sulfur feedstock costs ran ahead of realizations.
The next several months resolve three named questions. First, whether potash shipments stay inside the raised full-year band after the Canpotex export joint venture booked a full third-quarter order book. Second, whether proprietary retail margins keep compounding at a high-single-digit pace even if North American nutrient tonnes stay light. Third, whether the phosphate review, the idle Trinidad plant, and Brazilian retail produce a path that stops leaking cash. The equity at the recent print near $77 already embeds a mid-cycle fertilizer multiple rather than a twenty twenty-two style spike. The open issue is whether that multiple still underpays the downstream mix and the repurchase program if potash merely stays constructive.